Form 8-K · Current report
Procter & Gamble 8-K, filed Nov 3, 2026
- Filed
- CIK
- 0000080424
- Accession no.
- 0001628280-26-069608
Summary
Procter & Gamble closed an underwritten public offering of €3.25 billion in euro-denominated notes across four tranches — €750 million of 3.750% notes due 2030, €1 billion of 4.100% notes due 2034, €750 million of 4.250% notes due 2038 and €750 million of 4.625% notes due 2046 — under its existing shelf registration statement.
Key points
- The offering totaled €3.25 billion in aggregate principal amount across four tranches with maturities from 2030 to 2046.
- Coupons on the tranches range from 3.750% to 4.625%.
- The notes were issued under Procter & Gamble's Form S-3 registration statement (No. 333-299472).
- Legal opinions from Travonte Warren, Esq., the company's Director and Assistant General Counsel, and from Fried, Frank, Harris, Shriver & Jacobson LLP were filed as exhibits.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. On November 3, 2026, The Procter & Gamble Company (the “Company”) closed an underwritten public offering of €750,000,000 aggregate principal amount of 3.750% Notes due November 3, 2030, €1,000,000,000 aggregate principal amount of 4.100% Notes due November 3, 2034, €750,000,000 aggregate principal amount of 4.250% Notes due November 3, 2038 and €750,000,000 aggregate principal amount of 4.625% Notes due November 3, 2046 under the Company’s Registration Statement on Form S-3 (Registration No. 333-299472). Legal opinions related to these notes are attached hereto as Exhibits (5)(a) and (5)(b) and are incorporated herein by reference. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.